|1.||Eisenhut, Michael: 6 articles (01/2014 - 12/2002)|
|2.||Haberkorn, Uwe: 5 articles (01/2014 - 12/2002)|
|3.||Mier, Walter: 4 articles (01/2014 - 12/2002)|
|4.||Bauder-Wüst, Ulrike: 4 articles (04/2007 - 10/2004)|
|5.||Wolf, Markus: 4 articles (04/2007 - 10/2004)|
|6.||Friebe, Matthias: 3 articles (01/2014 - 12/2002)|
|7.||Babich, John W: 2 articles (01/2014 - 05/2010)|
|8.||Fujii, Yoshitaka: 2 articles (12/2011 - 03/2011)|
|9.||Mahmood, Ashfaq: 2 articles (10/2009 - 12/2002)|
|10.||Mier, W: 2 articles (01/2009 - 10/2000)|
07/01/1998 - "The use of benzamides has to be considered efficacious in the prevention of delayed vomiting and nausea."
12/09/1989 - "[Value of substituted benzamides in controlling acute post-cisplatin emesis]."
06/01/1990 - "The antiemetic and locomotor effects of two substituted benzamides, zacopride and batanopride (BMY25801), were compared in ferrets after bilateral 60Co irradiation at 2, 4 or 6 Gy. Both zacopride and BMY25801 were effective against emesis and related signs. "
03/01/2003 - "Among antiemetic drugs for the prevention of emesis, benzamides and in particular metoclopramide, are widely used in clinical practice. "
08/01/1988 - "A series of new substituted benzamides has been synthesized and evaluated for dopamine antagonist activity and for antagonism of cisplatin-induced emesis in the dog and in the ferret. "
08/01/1995 - "One of the benzamides with a blood clearance faster than that of BZA--0.06 vs. 0.2% I D/g--6 h p.i. gave the same tumor to blood and to organ ratios as BZA at 12-18 h p.i. Based on these preclinical data we hope to obtain good tumoral images 6 h p.i. in scintigraphic studies in man."
10/09/2014 - "Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of CK1δ and ε with nanomolar inhibitory activity on cancer cell proliferation."
10/01/2012 - "We synthesized a series of cationic lipo-benzamides and screened for in vitro anticancer activities against a panel of cancer and non-cancer cells. "
01/01/1997 - "These results support 3-CPA as a good candidate drug representing a new generation of benzamides for further clinical development as a cancer therapy drug."
07/26/2007 - "Benzamides 14d and 25, which display rapid and high tumor uptake, appear to be promising imaging agents for melanoma detection, while 14d, which displays a long lasting and high melanoma/nontarget ratio, is more suitable for evaluation as a potential radiotherapeutic."
|3.||Melanoma (Melanoma, Malignant)
01/01/1997 - "This article describes the synthesis of radioiodinated IMBA, N-(2-diethylaminoethyl)-3-[123I/131I]iodo-4-methoxybenzamide 8, its organ distribution, its comparison with BZA and other benzamides, and demonstrates the scintigraphic efficacy of the title compound with three melanoma patients. "
10/01/2001 - "Synthesis, characterization and comparative biodistribution study of a new series of p-iodine-125 benzamides as potential melanoma imaging agents."
01/01/2009 - "Indeed, several (99m)Tc complexes were found suitable for melanoma imaging; however, they were less eligible than radioiodinated benzamides. "
07/26/2007 - "Synthesis and evaluation of novel radioiodinated benzamides for malignant melanoma."
04/01/2007 - "Alkylating benzamides were reported previously to show a melanoma unselective, in general enhanced cytotoxicity. "
|4.||Acquired Immunodeficiency Syndrome (AIDS)
|5.||Postoperative Nausea and Vomiting (PONV)
01/01/2002 - "Antiemetic drugs available to treat or prevent PONV include phenothiazines, antihistamines, anticholinergics, benzamides, butyrophenones and 5-HT(3) antagonists. "
02/01/2000 - "Commonly used older, traditional antiemetics for PONV include the anticholinergics (scopolamine), phenothiazines (promethazine), antihistamines (diphenhydramine), butyrophenones (droperidol) and benzamides (metoclopramide). "
12/01/2011 - "Secondly, a wide range of prophylactic antiemetics, including butyrophenones (droperidol), benzamides (metoclopramide), glucocorticoids (dexamethasone), clonidine, a small dose of propofol, and serotonin receptor (SR) antagonists (ondansetron, granisetron, tropisetron, dolasetron, ramosetron, and palonosetron), are available for preventing PONV. "
03/01/2011 - "Second, prophylactic antiemetics including antihistamines (dimenhydrinate), phenothiazines (perphenazine), butyrophenones (droperidol), benzamides (metoclopramide), dexamethasone, and serotonin receptor antagonists (ondansetron, granisetron, tropisetron, dolasetron, and ramosetron) are available for preventing PONV after LC. "
|2.||Histone Deacetylase Inhibitors
|4.||Hydroxamic Acids (Hydroxamic Acid)
|1.||Drug Therapy (Chemotherapy)
|2.||Heterologous Transplantation (Xenotransplantation)